本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

15.75
+0.30001.94%
盘后15.750.00000.00%16:20 EDT
成交量:112.85万
成交额:1,790.20万
市值:16.57亿
市盈率:-10.17
高:16.30
开:15.64
低:15.30
收:15.45
数据加载中...
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/06/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]